The incidence of deepening of upper eyelid sulcus (DUES) caused by prostaglandin (PG) analogues

The incidence of deepening of upper eyelid sulcus (DUES) caused by prostaglandin (PG) analogues - Relationship between PG analogues and the incidence of deepening of upper eyelid sulcus (DUES)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005084

Enrollment

Registered

2011-02-19

Start date

2009-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with open angle glaucoma (OAG)

Interventions

The subjects of the current study included the patients with open angle glaucoma (OAG) who were required further intraocular pressure (IOP) reduction. PG analogue was newly started or switched to ano

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with open angle glaucoma (OAG)

Exclusion criteria

Exclusion criteria: Treated or treating ocular or systemic diseases,Past history of ocular surgery Allergy for PG analogues,Wearing contact lenses during the study,Participation in other clinical researches recently,Using other glaucoma drugs except PG analogues, Using steroid drugs topically or systemically

Design outcomes

Primary

Measure	Time frame
The change of upper eyelid sulcus, IOP, Subjective symptom of DUES	—

Countries

Japan

Contacts

Public ContactRei Sakata

Tokyo Metropolitan Geriatric Hospital Department of Ophthalmology

03-3964-1141

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026